These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

487 related items for PubMed ID: 17391170

  • 41. Insulin detemir versus insulin glargine for type 2 diabetes mellitus.
    Swinnen SG, Simon AC, Holleman F, Hoekstra JB, Devries JH.
    Cochrane Database Syst Rev; 2011 Jul 06; 2011(7):CD006383. PubMed ID: 21735405
    [Abstract] [Full Text] [Related]

  • 42. Randomized, open-label, parallel-group evaluations of basal-bolus therapy versus insulin lispro premixed therapy in patients with type 2 diabetes mellitus failing to achieve control with starter insulin treatment and continuing oral antihyperglycemic drugs: a noninferiority intensification substudy of the DURABLE trial.
    Miser WF, Arakaki R, Jiang H, Scism-Bacon J, Anderson PW, Fahrbach JL.
    Clin Ther; 2010 May 06; 32(5):896-908. PubMed ID: 20685497
    [Abstract] [Full Text] [Related]

  • 43. Insulin detemir lowers the risk of hypoglycaemia and provides more consistent plasma glucose levels compared with NPH insulin in Type 1 diabetes.
    Kølendorf K, Ross GP, Pavlic-Renar I, Perriello G, Philotheou A, Jendle J, Gall MA, Heller SR.
    Diabet Med; 2006 Jul 06; 23(7):729-35. PubMed ID: 16842476
    [Abstract] [Full Text] [Related]

  • 44. Initiation of insulin glargine therapy in type 2 diabetes subjects suboptimally controlled on oral antidiabetic agents: results from the AT.LANTUS trial.
    Davies M, Lavalle-González F, Storms F, Gomis R, AT.LANTUS Study Group.
    Diabetes Obes Metab; 2008 May 06; 10(5):387-99. PubMed ID: 18355327
    [Abstract] [Full Text] [Related]

  • 45. Comparison of insulin analogue regimens in people with type 2 diabetes mellitus in the PREFER Study: a randomized controlled trial.
    Liebl A, Prager R, Binz K, Kaiser M, Bergenstal R, Gallwitz B, PREFER Study Group.
    Diabetes Obes Metab; 2009 Jan 06; 11(1):45-52. PubMed ID: 18643839
    [Abstract] [Full Text] [Related]

  • 46. Insulin analogues (insulin detemir and insulin aspart) versus traditional human insulins (NPH insulin and regular human insulin) in basal-bolus therapy for patients with type 1 diabetes.
    Hermansen K, Fontaine P, Kukolja KK, Peterkova V, Leth G, Gall MA.
    Diabetologia; 2004 Apr 06; 47(4):622-9. PubMed ID: 15298338
    [Abstract] [Full Text] [Related]

  • 47. Glimepiride combined with morning insulin glargine, bedtime neutral protamine hagedorn insulin, or bedtime insulin glargine in patients with type 2 diabetes. A randomized, controlled trial.
    Fritsche A, Schweitzer MA, Häring HU, 4001 Study Group.
    Ann Intern Med; 2003 Jun 17; 138(12):952-9. PubMed ID: 12809451
    [Abstract] [Full Text] [Related]

  • 48. Better long-term glycaemic control with the basal insulin glargine as compared with NPH in patients with Type 1 diabetes mellitus given meal-time lispro insulin.
    Porcellati F, Rossetti P, Pampanelli S, Fanelli CG, Torlone E, Scionti L, Perriello G, Bolli GB.
    Diabet Med; 2004 Nov 17; 21(11):1213-20. PubMed ID: 15498088
    [Abstract] [Full Text] [Related]

  • 49. [Effectiveness and safety of initiation of once-daily insulin detemir in Chinese patients with type 2 diabetes previously treated with different quantities of oral anti-diabetic drugs: subgroup analysis of the Chinese SOLVE™ Study].
    Pan C, Ji L, Lu J, Yang W, Zhou Z, Chinese SOLVE™ Study.
    Zhonghua Nei Ke Za Zhi; 2015 Jul 17; 54(7):612-7. PubMed ID: 26359024
    [Abstract] [Full Text] [Related]

  • 50. Influence of baseline glycemia on outcomes with insulin glargine use in patients uncontrolled on oral agents.
    Banerji MA, Baron MA, Gao L, Blonde L.
    Postgrad Med; 2014 May 17; 126(3):111-25. PubMed ID: 24918797
    [Abstract] [Full Text] [Related]

  • 51. Long-acting insulin analogues versus NPH insulin (human isophane insulin) for type 2 diabetes mellitus.
    Horvath K, Jeitler K, Berghold A, Ebrahim SH, Gratzer TW, Plank J, Kaiser T, Pieber TR, Siebenhofer A.
    Cochrane Database Syst Rev; 2007 Apr 18; (2):CD005613. PubMed ID: 17443605
    [Abstract] [Full Text] [Related]

  • 52. Improving glycemic control with insulin detemir using the 303 Algorithm in insulin naïve patients with type 2 diabetes: a subgroup analysis of the US PREDICTIVE 303 study.
    Selam JL, Koenen C, Weng W, Meneghini L.
    Curr Med Res Opin; 2008 Jan 18; 24(1):11-20. PubMed ID: 18021495
    [Abstract] [Full Text] [Related]

  • 53. Lower risk of hypoglycemia with insulin detemir than with neutral protamine hagedorn insulin in older persons with type 2 diabetes: a pooled analysis of phase III trials.
    Garber AJ, Clauson P, Pedersen CB, Kølendorf K.
    J Am Geriatr Soc; 2007 Nov 18; 55(11):1735-40. PubMed ID: 17979896
    [Abstract] [Full Text] [Related]

  • 54. Patient-directed titration for achieving glycaemic goals using a once-daily basal insulin analogue: an assessment of two different fasting plasma glucose targets - the TITRATE study.
    Blonde L, Merilainen M, Karwe V, Raskin P, TITRATE Study Group.
    Diabetes Obes Metab; 2009 Jun 18; 11(6):623-31. PubMed ID: 19515182
    [Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56. Differences between long-acting insulins for the treatment of type 2 diabetes.
    Jensen MG, Hansen M, Brock B, Rungby J.
    Expert Opin Pharmacother; 2010 Aug 18; 11(12):2027-35. PubMed ID: 20642370
    [Abstract] [Full Text] [Related]

  • 57. Insulin detemir: a review of its use in the management of diabetes mellitus.
    Keating GM.
    Drugs; 2012 Dec 03; 72(17):2255-87. PubMed ID: 23110609
    [Abstract] [Full Text] [Related]

  • 58. An analysis of early insulin glargine added to metformin with or without sulfonylurea: impact on glycaemic control and hypoglycaemia.
    Fonseca V, Gill J, Zhou R, Leahy J.
    Diabetes Obes Metab; 2011 Sep 03; 13(9):814-22. PubMed ID: 21481127
    [Abstract] [Full Text] [Related]

  • 59. Basal insulin therapy in type 2 diabetes: 28-week comparison of insulin glargine (HOE 901) and NPH insulin.
    Rosenstock J, Schwartz SL, Clark CM, Park GD, Donley DW, Edwards MB.
    Diabetes Care; 2001 Apr 03; 24(4):631-6. PubMed ID: 11315821
    [Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 25.